- Home
- AGM vs GLPG Comparison
AGM vs GLPG Comparison
Compare AGM & GLPG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AGM
- GLPG
- Stock Information
- Founded
- AGM 1987
- GLPG 1999
- Country
- AGM United States
- GLPG Belgium
- Employees
- AGM N/A
- GLPG N/A
- Industry
- AGM Finance Companies
- GLPG Biotechnology: Pharmaceutical Preparations
- Sector
- AGM Finance
- GLPG Health Care
- Exchange
- AGM Nasdaq
- GLPG Nasdaq
- Market Cap
- AGM 2.2B
- GLPG 1.8B
- IPO Year
- AGM N/A
- GLPG 2005
- Fundamental
- Price
- AGM $185.74
- GLPG $25.32
- Analyst Decision
- AGM Hold
- GLPG Sell
- Analyst Count
- AGM 1
- GLPG 4
- Target Price
- AGM $230.00
- GLPG $25.33
- AVG Volume (30 Days)
- AGM 37.3K
- GLPG 471.2K
- Earning Date
- AGM 05-09-2025
- GLPG 04-23-2025
- Dividend Yield
- AGM 3.23%
- GLPG N/A
- EPS Growth
- AGM N/A
- GLPG N/A
- EPS
- AGM 16.13
- GLPG N/A
- Revenue
- AGM $357,734,000.00
- GLPG $311,493,731.00
- Revenue This Year
- AGM $8.80
- GLPG N/A
- Revenue Next Year
- AGM $8.07
- GLPG N/A
- P/E Ratio
- AGM $11.50
- GLPG N/A
- Revenue Growth
- AGM N/A
- GLPG 18.32
- 52 Week Low
- AGM $159.64
- GLPG $22.36
- 52 Week High
- AGM $217.60
- GLPG $31.23
- Technical
- Relative Strength Index (RSI)
- AGM 60.56
- GLPG 45.40
- Support Level
- AGM $173.42
- GLPG $25.20
- Resistance Level
- AGM $179.02
- GLPG $27.64
- Average True Range (ATR)
- AGM 3.87
- GLPG 0.59
- MACD
- AGM 1.50
- GLPG -0.09
- Stochastic Oscillator
- AGM 89.57
- GLPG 23.93
About AGM Federal Agricultural Mortgage Corporation
Federal Agricultural Mortgage Corp provides agricultural real estate and rural housing mortgage loans in the secondary market in the U.S. Its operations consist of seven segments: Farm & Ranch, Corporate AgFinance, Power & Utilities, Broadband Infrastructure, Renewable Energy, Funding, and Investments. The company purchases eligible mortgage loans secured by first liens on agricultural real estate and rural housing under the Farm & Ranch line of business. Its subsidiary purchases portions of certain agricultural, rural development, business and industry, and community facilities loans guaranteed by the USDA.
About GLPG Galapagos NV
Galapagos NV is a fully integrated biotechnology company focused on discovering, developing, and commercializing medicines. The company is committed to improving patients' lives world-wide by targeting diseases with high unmet needs. Its R&D capabilities cover multiple drug modalities, including small molecules and cell therapies. Its portfolio comprises discovery through to commercialized programs in immunology, oncology, and other indications. Its first medicine for rheumatoid arthritis and ulcerative colitis is available in Europe and Japan. It derives maximum revenue from United States of America.